Description

Treatment of schizophrenia in adults and adolescents aged 15 years and older. ABILICARE is indicated for the treatment of moderate to severe manic episodes of bipolar I disorder and for the prevention of recurrence of manic episodes in adults who have had predominantly manic episodes and whose manic episodes have responded to treatment with aripiprazole. ABILICARE is indicated for the treatment of moderate to severe manic episodes of bipolar I disorder in adolescents aged 13 years and older for up to 12 weeks.